Effect of Gut Microbiome Intervention on Aging Via Oral FMT
Condition(s) studied
Investigational drug(s) / intervention(s)
FMT capsules: FMT capsules containing extensively screened donor stool.
Placebo capsules: Placebo capsules that do not contain donor stool or any active drug.
Study summary
A severe public health issue facing global population is aging. Increasing preclinical and clinical data indicate the contribution of gut microbiome on aging and aging-related diseases such as cardiovascular disease, Alzheimer Disease, and diabetes. Interventions on microbiota are developed including prebiotics, probiotics, and fecal microbial transplantation (FMT). FMT via oral capsules also advances in recent with limited safety concerns compared with invasive routes. A hypothesis is thus raised that gut microbiome intervention via oral FMT can be a potential safe approach to encourage healthy aging, with multiple aspects evaluated for clinical phenotype of frailty, anthropometric measurement, cognitive function, cardiovascular aging, physical function, living activity, hippocampal volume, telomere length, cognitive biomarkers, inflammatory biomarkers, altered microbial composition and metabolites.
Eligibility
Primary outcome measure(s)
- Proportion of participants with reduced frailty score at week 96 follow-up — week 96
Frailty score via CHS criteria of five frailty components, compared with baseline
Trial sites (6)
| Facility | City | Region | Status |
|---|---|---|---|
| Beijing Chao-yang Hospital, Capital Medical University | Beijing | Beijing Municipality | Recruiting |
| Beijing Hospital | Beijing | Beijing Municipality | Recruiting |
| Chinese People's Liberation Army (PLA) General Hospital | Beijing | Beijing Municipality | Recruiting |
| Xuanwu Hospital, Capital Medical University | Beijing | Beijing Municipality | Recruiting |
| Huadong Hospital Affiliated to Fudan University | Shanghai | Shanghai Municipality | Recruiting |
| Zhejiang Hospital | Hangzhou | Zhejiang | Recruiting |
More Chinese Academy of Medical Sciences, Fuwai Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05598112 on ClinicalTrials.gov ↗ ← All trials in China